You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Pharmacy Articles
Popular Pharmacy Articles
Highly Recommended Pharmacy Articles
Send a link to this page to your friends and colleagues.
The FDA has spoken: the heart risk warnings on labels of Avandia (rosiglitazone) and Actos (pioglitazone) will now be surrounded by an emphatic black outline known as a black box. Black boxes will also be added to the warnings on Avandaryl (rosiglitazone and glimepiride), Avandamet (rosiglitazone and metformin), and Duetact (pioglitazone and glimepiride).
To catch up on the whole Avandia hoopla, read "The Latest About Avandia and Actos", "Amid Accusatory Debate, FDA Puts Black Box Warning on Avandia and Actos", and "Updated: Analysis Associates Avandia With Greater Risk of Heart Attack".
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.